Literature DB >> 16600053

The characteristics of the spectra of superior venae cavae in patients with right heart failure.

Hua-Ping Jia1, Yun-You Duan, Tie-Sheng Cao, Li-Jun Yuan, Juan Li.   

Abstract

BACKGROUND: Aimed to elucidate the characteristics of the spectra of superior venae cavae (SVC) in respiratory cycles in patients with right heart failure.
METHODS: The spectra of SVC of 30 patients with right heart failure and 30 paired healthy subjects were recorded through right supraclavicular fossa view. The profiles of spectra of superior venae cavae were observed, and peak velocity and velocity time integral (VTI) of every wave of SVC under spontaneous respiration were measured for statistical analysis.
RESULTS: In healthy subjects, the peak velocities and VTI of S wave and D wave increased in inspiratory phase and diminished in expiratory phase, and which of S wave were larger than which of D wave in whole respiratory cycle. In patients with right heart failure, spectral variations of SVC could be classified into three patterns: Pattern I: peak velocities and VTI of S wave were larger than that of D wave in early inspiratory phase, but peak velocities and VTI of D wave were larger than those of S wave in late inspiratory phase and early expiratory phase [Pattern I-1], even in whole respiratory cycle [Pattern I-2]; Pattern II: the S wave disappeared and was substituted by inverse wave with low amplitude in whole respiratory cycle. Pattern III: the profiles of the spectra of SVC in patients were similar to those of healthy subjects. In the whole, the respiratory variation ratios of peak velocities and VTI of S wave and D wave were diminished in patients compared with those in healthy subjects.
CONCLUSION: The spectra of superior venae cavae in patients with right heart failure were abnormal, and these characteristics could be used as signs in evaluating right heart failure.

Entities:  

Mesh:

Year:  2006        PMID: 16600053      PMCID: PMC1501053          DOI: 10.1186/1476-7120-4-21

Source DB:  PubMed          Journal:  Cardiovasc Ultrasound        ISSN: 1476-7120            Impact factor:   2.062


  8 in total

1.  Superior vena cava Doppler flow velocity patterns in pericardial disease.

Authors:  B F Byrd; R W Linden
Journal:  Am J Cardiol       Date:  1990-06-15       Impact factor: 2.778

2.  Superior vena caval blood flow velocities in adults: a Doppler echocardiographic study.

Authors:  M L Cohen; B S Cohen; I Kronzon; G W Lighty; H E Winer
Journal:  J Appl Physiol (1985)       Date:  1986-07

3.  Doppler velocimetry in superior vena cava provides useful information on the right circulatory function in patients with congestive heart failure.

Authors:  S Ghio; F Recusani; R Sebastiani; C Klersy; C Raineri; C Campana; L Lanzarini; A Gavazzi; L Tavazzi
Journal:  Echocardiography       Date:  2001-08       Impact factor: 1.724

4.  Effects of age and physiologic variables on right ventricular filling dynamics in normal subjects.

Authors:  A L Klein; D Y Leung; R D Murray; L H Urban; K R Bailey; A J Tajik
Journal:  Am J Cardiol       Date:  1999-08-15       Impact factor: 2.778

5.  [Venous return disturbances in chronic pulmonary disease: a study using pulsed Doppler echocardiography].

Authors:  S Kobayashi; S Izumi; H Toda; T Ohta; H Ochi; Y Matsuno; R Murakami; S Morioka; K Moriyama
Journal:  J Cardiol       Date:  1991       Impact factor: 3.159

6.  [Factors regulating venous return: analysis based on the respiratory variations of superior vena caval flow].

Authors:  H Toda; S Izumi; S Kobayashi; T Ohta; H Ochi; T Shimada; R Murakami; S Morioka; K Moriyama
Journal:  J Cardiol       Date:  1991       Impact factor: 3.159

7.  Normal patterns of flow in the superior caval, hepatic and pulmonary veins as measured using Doppler echocardiography during childhood.

Authors:  Canan Ayabakan; Süheyla Ozkutlu
Journal:  Cardiol Young       Date:  2003-04       Impact factor: 1.093

8.  Phasic venous return abnormality in chronic pulmonary diseases: pulsed Doppler echocardiography study.

Authors:  S Izumi; K Moriyama; S Kobayashi; H Toda; T Ohta; Y Matsuno; T Shimada; R Murakami; S Morioka
Journal:  Intern Med       Date:  1994-06       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.